Latest News in the pharma Industry
Top Stories
Ariad to be acquired by Takeda for $5.2 billion
9 Jan 2017
Ariad stockholders to receive $24.00 per share in cash.
Read more
Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic
16 Dec 2016
Authorized generic offered at more than 50% below wholesale acquisition cost of EpiPen auto-injector.
Read more
Lonza to acquire Capsugel
15 Dec 2016
Acquisition will make Lonza a fully integrated solutions provider in oral delivery technologies and active ingredients to the consumer healthcare and nutrition markets.
Read more
BMS strengthens capabilities with evolution of its US geographic footprint
13 Dec 2016
Company will also close its Hopewell, New Jersey site and will not renew its lease at the Lake Union Steam Plant site in Seattle, Washington.
Read more
Pfizer refutes the findings set out in the CMA decision
8 Dec 2016
Pharma giant says it complied with established competition law.
Read more
Hopes dashed for new Alzheimer drug
23 Nov 2016
Lilly's solanezumab fails to meet primary endpoint of Phase III study.
Read more
Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor
2 Nov 2016
Bococizumab deemed unlikely to provide value to patients, physicians, or shareholders.
Read more
Fighting cancer with the power of immunity
24 Oct 2016
New treatment elicits two-pronged immune response that destroys tumors in mice.
Read more
Pfizer announces US availability of biosimilar Inflectra
21 Oct 2016
Inflectra will be the first biosimilar monoclonal antibody (mAb) to be available in the US.
Read more
Mylan agrees to settlement on Medicaid Rebate Classification for EpiPen Auto-Injector
10 Oct 2016
The terms of the settlement do not provide for any finding of wrongdoing on the part of Mylan Inc. or any of its affiliated entities or personnel.
Read more
Pfizer decides to remain as one company
26 Sep 2016
Company to continue to operate as one company with two distinct and complementary businesses to retain operating strength and financial flexibility.
Read more
Leading pharmaceutical companies present industry roadmap to combat antimicrobial resistance
25 Sep 2016
Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance.
Read more